After a long trail race, some of your red blood cells may not bend the way they should. That matters because red blood cells have a tight job description.
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...